Artia Global Partners Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$499.4M
Q ending 2026-03-31
Prior quarter
$705.8M
Q ending 2025-12-31
Change
-29.2% QoQ · +26.4% YoY
Positions
50
reported holdings
Largest positions
All 50 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Insmed Inc | INSM | Shares | $102.8M | 629K |
| Abivax Sa | ABVX | Shares | $66.9M | 601K |
| Insmed Inc | INSM | Put | $45.7M | 280K |
| Eli Lilly & Co | LLY | Shares | $35.2M | 38K |
| Trevi Therapeutics Inc | TRVI | Shares | $24.0M | 2.0M |
| Argenx Se | ARGX | Shares | $21.7M | 30K |
| Astrazeneca Plc | Shares | $18.8M | 95K | |
| Newamsterdam Pharma Company | Shares | $16.1M | 504K | |
| Dianthus Therapeutics Inc | DNTH | Shares | $13.7M | 163K |
| Revolution Medicines Inc | RVMD | Shares | $12.2M | 125K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $10.8M | 144K |
| Moderna Inc | MRNA | Call | $10.2M | 200K |
| Eyepoint Inc | EYPT | Shares | $9.9M | 767K |
| Quest Diagnostics Inc | DGX | Shares | $8.0M | 41K |
| Alumis Inc | ALMS | Shares | $7.2M | 325K |
| Viking Therapeutics Inc | VKTX | Shares | $5.9M | 181K |
| Merck & Co Inc | MRK | Shares | $5.6M | 47K |
| Terns Pharmaceuticals Inc | 430 | Shares | $5.5M | 105K |
| Johnson & Johnson | JNJ | Shares | $5.5M | 23K |
| Sionna Therapeutics Inc | SION | Shares | $4.8M | 120K |
| Scholar Rock Hldg Corp | SRRK | Shares | $4.7M | 96K |
| Rapport Therapeutics Inc | RAPP | Shares | $4.3M | 139K |
| Ascendis Pharma A/S | Shares | $4.1M | 18K | |
| Belite Bio Inc | BLTE | Shares | $4.0M | 25K |
| Xenon Pharmaceuticals Inc | XENE | Shares | $3.8M | 65K |
| Mineralys Therapeutics Inc | MLYS | Shares | $3.7M | 138K |
| Roivant Sciences Ltd | Shares | $3.6M | 130K | |
| Palisade Bio Inc | PALI | Shares | $3.5M | 2.0M |
| Biogen Inc | BIIB | Shares | $3.4M | 18K |
| Prokidney Corp | PROK | Shares | $3.2M | 1.8M |
| Abbvie Inc | ABBV | Shares | $3.2M | 15K |
| United Therapeutics Corp Del | UTHR | Shares | $3.0M | 5K |
| Bright Minds Biosciences Inc | DRUG | Shares | $2.8M | 38K |
| Protagonist Therapeutics Inc | PTGX | Shares | $2.4M | 23K |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $2.3M | 68K |
| Brightspring Health Svcs Inc | BTSG | Shares | $2.3M | 54K |
| Travere Therapeutics Inc | TVTX | Shares | $2.1M | 71K |
| Edgewise Therapeutics Inc | EWTX | Shares | $2.1M | 66K |
| Celcuity Inc | CELC | Shares | $1.8M | 16K |
| Bridgebio Pharma Inc | BBIO | Shares | $1.5M | 20K |
| Kiniksa Pharmaceuticals Intl | Shares | $1.4M | 29K | |
| Cytokinetics Inc | CYTK | Shares | $1.1M | 16K |
| Enliven Therapeutics Inc | ELVN | Shares | $819K | 21K |
| Praxis Precision Medicines I | PRAX | Shares | $805K | 3K |
| Tenax Therapeutics Inc | TENX | Shares | $673K | 42K |
| Kodiak Sciences Inc | KOD | Shares | $649K | 17K |
| Nuvalent Inc | 5AX | Shares | $502K | 5K |
| Apogee Therapeutics Inc | APGE | Shares | $495K | 6K |
| Avalo Therapeutics Inc | AVTX | Shares | $433K | 29K |
| Pepgen Inc | PEPG | Shares | $363K | 205K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.